Alphatec Holdings (NASDAQ: ATEC) reported Q1 EPS of ($0.33), which may not compare to the analyst estimate of ($0.21). Revenue for the quarter came in at $30.1 million versus the consensus estimate of $29.42 million.

“During the first quarter, we saw continued solid business momentum,” said Pat Miles, Chairman and Chief Executive Officer. “While that momentum was interrupted by circumstances outside of our control, we will navigate through the current challenges with the same focus and execution that has driven our success to date. We are bringing clinical distinction to a market that yearns for it by fulfilling our commitment to launch 8 to 10 new products this year and continuing to expand our sales network with savvy distributors who know that the future of spine innovation is at ATEC. This company has faced and overcome a lot of adversity over the last few years. We are confident that we have the proven team and resilient culture to not only weather this crisis, but to emerge as the leader in spine innovation.”

For earnings history and earnings-related data on Alphatec Holdings (ATEC) click here.